Around 2:00 p.m. GMT, the Dow Jones advanced by 0.82%, the Nasdaq climbed by 1.38% and the S&P 500 by 0.86%.

On Friday, the Dow Jones had concluded at 32,803.47 points (+0.23%) and almost stable over the week (-0.13%).

The technology-dominated Nasdaq fell 0.50% to 12,657.55 points, but climbed 2.15% over the week.

The S&P 500 had dropped 0.16% to 4,145.19 points, but ended a third week in a row in the green (+0.36%).

"The highlight of the past week was the much better than expected jobs report...so markets shouldn't expect the central bank (Fed) to retreat (on the rates) until it controls inflation,” said Art Hogan of B. Riley Wealth.

After July's solid hires of 528,000 and a drop in the unemployment rate to 3.5%, market players were awaiting the publication of the CPI inflation index on Wednesday.

Projections bet on a slowdown in price increases to +0.2% over the month against +1.3% in June and 9.1% over one year, which could finally suggest that inflation has reached a peak .

Few indicators were on the menu on Monday but several companies were still publishing their results while the announcements of the quarterly accounts are coming to an end soon.

Some 432 of the S&P 500 companies reported their results and they were better than expected for 77% of them.

The passage by the United States Senate of an inflation reduction act, a plan of more than 430 billion dollars of investments in particular for the fight against climate change and the improvement of health services, seemed " be a positive catalyst," said Patrick O'Hare of Briefing.

The bill is expected to receive the approval of the House of Representatives on Friday.

Almost all sectors of the S&P 500 opened in the green, including discretionary consumer spending (+1.81%) but also materials (+1.60%) and real estate (+1.10%).

As equities rose, bond yields slipped a little, with that on ten-year Treasury bills coming in at 2.79% from 2.82% on Friday.

The American pharmaceutical group Pfizer yielded 0.42% after the announcement of the acquisition for approximately 5.4 billion dollars of Global Blood Therapeutics (GBT), manufacturer of a drug recently approved against a genetic disease, sickle cell anemia.

While GBT's purchase price was set at $68.50 per share, its stock rose 4.36% to $66.63.

Speculative stock in troubled home goods chain Bed Bath and Beyond jumped 40.81% to $11.49.

The American data analysis firm Palantir fell 13.35% after larger-than-expected losses in the second quarter, notably weighed down by unfavorable exchange rates.

Bitcoin was holding above the $24,000 mark, its highest for almost two months.

Cryptocurrency exchange Coinbase, which was due to report earnings after market close, was gaining strength, up 10%.

© 2022 AFP